Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Surgery Partners (SGRY) Shares Repurchased (2018)

Surgery Partners (SGRY) has disclosed Shares Repurchased for 2 consecutive years, with $2.0 million as the latest value for Q4 2018.

Quarterly Shares Repurchased changed N/A to $2.0 million in Q4 2018 from the year-ago period, while the trailing twelve-month figure was $2.0 million through Sep 2019, changed N/A year-over-year, with the annual reading at $2.0 million for FY2018, N/A changed from the prior year.
Shares Repurchased hit $2.0 million in Q4 2018 for Surgery Partners, roughly flat from $2.0 million in the prior quarter.
In the past five years, Shares Repurchased ranged from a high of $3.1 million in Q4 2014 to a low of $2.0 million in Q1 2018.